Skip to main content
Equibles

PHN · PHARMANUTRA S.P.A. · Financials

Use PHN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PHN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
72.8000 EUR 15-min delayed · Oct 7, 08:04 UTC
Rebalance outlook locked
Market Cap
699.95M EUR
Shares
9.58M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →

Browse captured authority reports and their original financial labels

Revenue
131.69M +14%
FY2025 Revenue FY2020–FY2025
Net Income
20.01M +20.8%
FY2025 Net Income FY2020–FY2025
Operating Margin
25.98% -0.9pp
FY2025 Operating Margin FY2020–FY2025
Operating Cash Flow
12.09M -30.8%
FY2023 Operating Cash Flow FY2020–FY2023

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
EUR 131.69M 115.5M 100.2M 82.72M 68.11M 56.45M
EUR 34.21M 31.04M 26.48M 24.36M 20.08M 15.56M
EUR 1.09M 1.62M 1.01M 150K 41K 62K
EUR 30.19M 27.16M 23.26M 23.42M 18.81M 13.3M
EUR 10.27M 10.61M 10.43M 8.37M 5.04M -770K
EUR 20.01M 16.57M 12.83M 15.05M 13.77M 14.07M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2025: 43.27M in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.